Literature DB >> 12452254

Is there a common mechanism of serotonin dysregulation in anorexia nervosa and obsessive compulsive disorder?

N Barbarich1.   

Abstract

Numerous studies have documented increased rates of comorbidity in patients with anorexia nervosa (AN) or obsessive compulsive disorder (OCD). The interaction of many possible factors influences this comorbidity, but one possible explanation involves the neurotransmitter serotonin, which is widely distributed in the brain and has been implicated in a number of psychological behaviours. Although low serotonin levels have been found in patients with impulsive and aggressive behaviour, high levels have been correlated with obsessive and compulsive behaviour. In an attempt to further our understanding of this relationship, a large number of studies have measured serotonin levels throughout different stages of illness in both AN and OCD; furthermore, serotonin challenge studies and drug treatment trials have provided further support for this theory. This paper discusses the evidence supporting the view that the obsessive behaviour characteristic of AN and OCD may be partially due to a dysregulation in the serotonergic system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452254     DOI: 10.1007/bf03327460

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  40 in total

1.  CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain.

Authors:  W H Kaye; H E Gwirtsman; D T George; D C Jimerson; M H Ebert
Journal:  Biol Psychiatry       Date:  1988-01-01       Impact factor: 13.382

2.  Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls.

Authors:  J F Leckman; W K Goodman; G M Anderson; M A Riddle; P B Chappell; M T McSwiggan-Hardin; C J McDougle; L D Scahill; S I Ort; D L Pauls
Journal:  Neuropsychopharmacology       Date:  1995-02       Impact factor: 7.853

Review 3.  OCD: where the serotonin selectivity story begins.

Authors:  T A Pigott
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

4.  The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression.

Authors:  G M Goodwin; C G Fairburn; P J Cowen
Journal:  Arch Gen Psychiatry       Date:  1987-11

Review 5.  Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.

Authors:  W H Kaye; T E Weltzin
Journal:  J Clin Psychiatry       Date:  1991-12       Impact factor: 4.384

6.  m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.

Authors:  W K Goodman; C J McDougle; L H Price; L C Barr; O F Hills; J F Caplik; D S Charney; G R Heninger
Journal:  Biol Psychiatry       Date:  1995-08-01       Impact factor: 13.382

7.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.

Authors:  P Thorén; M Asberg; B Cronholm; L Jörnestedt; L Träskman
Journal:  Arch Gen Psychiatry       Date:  1980-11

8.  Dimensions of perfectionism across the anxiety disorders.

Authors:  M M Antony; C L Purdon; V Huta; R P Swinson
Journal:  Behav Res Ther       Date:  1998-12

9.  Eating disorder history in women with obsessive compulsive disorder.

Authors:  M B Tamburrino; R Kaufman; J Hertzer
Journal:  J Am Med Womens Assoc (1972)       Date:  1994 Jan-Feb

10.  CSF neurochemistry of women with anorexia nervosa and normal women.

Authors:  R H Gerner; D J Cohen; L Fairbanks; G M Anderson; J G Young; M Scheinin; M Linnoila; B A Shaywitz; T A Hare
Journal:  Am J Psychiatry       Date:  1984-11       Impact factor: 18.112

View more
  1 in total

1.  Obsessive compulsive disorder as early manifestation of B12 deficiency.

Authors:  Maryam Valizadeh; Nasim Valizadeh
Journal:  Indian J Psychol Med       Date:  2011-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.